Approval · Notice of Compliance 35591 · 2025
PREMARIN: Notice of Compliance 35591
Issued June 27, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35591
- Date
- June 27, 2025
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph with new safety information
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PREMARIN | Not yet assigned | — |
Medicinal ingredients
- CONJUGATED ESTROGENS 0.3 MG per TAB
- CONJUGATED ESTROGENS 0.625 MG per TAB
- CONJUGATED ESTROGENS 1.25 MG per TAB